activesellsec_filings

ACN 10-Q report for 2025-11-30

Accenture filed its Form 10‑Q for the quarter ended November 30, 2025. The filing includes condensed consolidated balance sheets, income statements, statements of comprehensive income, shareholders’ equity, cash flows, and accompanying notes for the three months ended November 30, 2025 and 2024.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

ACN — Accenture plc: quarterly filing confirming reporting status and providing interim financial statements and selected disclosures for the period ended November 30, 2025.

ACNAccenture plcsellopen

Accenture plc provides strategy and consulting, Industry X, Song, and technology and operations services across the Americas, Europe, the Middle East and Africa, and the Asia Pacific.

Confidence: 60 / 100Start: $269.96Latest: $172.68Return: 36.03%

ACN 10‑Q report for 2025‑11‑30 (acn-20251130) — Filing includes: table of contents and unaudited consolidated financial statements for the three months ended November 30, 2025 and 2024 (balance sheet, income statement, comprehensive income, shareholders’ equity, cash flows) and notes. Key line items disclosed in the excerpt: cash and cash equivalents $9,649,405; total assets $64,698,463; total shareholders’ equity $31,922,282; revenues $18,742,125 for the three months ended November 30, 2025; net income $2,241,896; earnings per Class A ordinary share (diluted) $3.54; cash dividends per share $1.63. The filing confirms reporting status and provides interim financials; it is actionable primarily as a verified source of interim financial results and capital‑structure metrics but does not by itself constitute a complete investment recommendation. Follow the full 10‑Q for MD&A, risk factors, liquidity discussion, and other disclosures before trading.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Primary source: Accenture plc Form 10‑Q (Quarterly Report) for the period ended November 30, 2025. Document contains unaudited consolidated financial statements (balance sheet, income statement, comprehensive income, shareholders’ equity, cash flows) and table of contents indicating MD&A, market risk disclosures, controls and procedures, and other standard 10‑Q sections.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10‑Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high‑confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As‑is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk‑factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt of CleanSpark, Inc.’s Form 10‑Q for the quarter ended March 31, 2026 is primarily the cover page and identifies securities (common stock and redeemable warrants with exercise terms) but provides no operating/financial results, guidance, risks, or MD&A. Actionability is therefore limited to capital‑structure/dilution considerations.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover‑page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk‑factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Prepared from the filed Form 10‑Q; authorship reflects the filing registrant (Accenture plc) and the document’s included unaudited consolidated financial statements and notes.

Unlock full thesis monitoring

Review the full Form 10‑Q (SEC filing) for complete disclosures, notes, and Management’s Discussion & Analysis before making investment decisions.